noom compounded tirzepatide What Is & Is It the Right Solution for You? led and built for women Noom GLP-1 Review 2026: Great

And I would expect in the future in a post shortage world, this also continues to exist for patients as an access point

In Study 3, statistically significantly more patients randomized to SAXENDA than placebo had not gained more than 0.5% of body weight from randomization to Week 56

2016;119:e3975

If your patient base is distributed nationally, licensing yourself as an NP in FPA states while maintaining compliant physician collaboration for restricted-state patients gives you the most operational flexibility

Its use is justified for weight loss and maintenance in people with Obesity: Body mass index (BMI) 30 kg/m